Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4929097 and Vismodegib in Advanced/Metastatic Sarcomas
NCT01154452Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2010
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RO4929097, vismodegib in sarcoma, sponsored by National Cancer Institute. Started Jun 2010; status: completed.
02
Drugs
RO4929097vismodegib
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT01154452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01154452.